• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用母体血浆中游离DNA片段计数对染色体失衡进行无创产前检测的理论性能。

Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma.

作者信息

Benn Peter, Cuckle Howard

机构信息

Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT, USA.

出版信息

Prenat Diagn. 2014 Aug;34(8):778-83. doi: 10.1002/pd.4366. Epub 2014 Apr 30.

DOI:10.1002/pd.4366
PMID:24676912
Abstract

OBJECTIVE

The aim of this study was to calculate the theoretical performance of non-invasive prenatal testing based on counting methods.

METHODS

The calculations were based on Gaussian distributions of the percent cell-free DNA from selected chromosome regions in affected and normal pregnancies. The means were derived from the relative genomic size of the chromosome region and the fetal fraction. The standard deviations were derived from the bivariate distributions of proportional counts. Depth of sequencing was varied from 50,000,000 to 100,000 and fetal fraction from 20% to 3%. Detection rate was estimated for a fixed 0.13% false-positive rate.

RESULTS

When either depth or fetal fraction is high, expected Down syndrome screening detection rates are high. However, when fetal fraction is low, deeper sequencing is required to obtain high detection rates. For microdeletion and microduplication screening, deeper sequencing is routinely required to consistently achieve high detection rates. There are small differences in the ability to detect a microdeletion compared with a duplication of the same size.

CONCLUSION

While the theoretical calculations do not necessarily reflect the performance of currently available non-invasive prenatal testing tests, it confirms that fetal fraction is a key factor. Efficacy can be substantially altered depending on the abnormality under investigation and the depth of sequencing.

摘要

目的

本研究旨在计算基于计数方法的无创产前检测的理论性能。

方法

计算基于受影响和正常妊娠中选定染色体区域的游离DNA百分比的高斯分布。均值来自染色体区域的相对基因组大小和胎儿游离DNA比例。标准差来自比例计数的双变量分布。测序深度从50000000变化到100000,胎儿游离DNA比例从20%变化到3%。在固定的0.13%假阳性率下估计检测率。

结果

当深度或胎儿游离DNA比例较高时,预期的唐氏综合征筛查检测率较高。然而,当胎儿游离DNA比例较低时,需要更深的测序才能获得高检测率。对于微缺失和微重复筛查,通常需要更深的测序才能持续获得高检测率。检测相同大小的微缺失与微重复的能力存在细微差异。

结论

虽然理论计算不一定反映当前可用的无创产前检测的性能,但它证实了胎儿游离DNA比例是一个关键因素。根据所研究的异常情况和测序深度,效能可能会有很大改变。

相似文献

1
Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma.利用母体血浆中游离DNA片段计数对染色体失衡进行无创产前检测的理论性能。
Prenat Diagn. 2014 Aug;34(8):778-83. doi: 10.1002/pd.4366. Epub 2014 Apr 30.
2
Genome-wide normalized score: a novel algorithm to detect fetal trisomy 21 during non-invasive prenatal testing.全基因组标准化评分:一种在无创产前检测中检测胎儿21三体综合征的新算法。
Ultrasound Obstet Gynecol. 2014 Jul;44(1):25-30. doi: 10.1002/uog.13377. Epub 2014 Jun 12.
3
[Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].[母体血浆中游离胎儿DNA检测在染色体异常产前诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):808-12.
4
Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing.利用母体血浆 DNA 的大规模平行测序进行无创性产前检测:从分子核型分析到胎儿全基因组测序。
Reprod Biomed Online. 2013 Dec;27(6):593-8. doi: 10.1016/j.rbmo.2013.08.008. Epub 2013 Sep 7.
5
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.母体外周血游离胎儿 DNA 片段对常见胎儿非整倍体的下一代测序检测的影响。
Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31.
6
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics.妊娠 11-13 周时母体外周血游离胎儿细胞中胎儿分数:与母亲和胎儿特征的关系。
Ultrasound Obstet Gynecol. 2013 Jan;41(1):26-32. doi: 10.1002/uog.12331. Epub 2012 Dec 4.
7
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.在常规筛查的早孕期人群中进行胎儿三体的非侵入性产前检测。
Am J Obstet Gynecol. 2012 Nov;207(5):374.e1-6. doi: 10.1016/j.ajog.2012.08.033. Epub 2012 Sep 19.
8
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].游离胎儿DNA在母体血浆中用于无创产前诊断的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7.
9
Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.双胎妊娠中通过母体血浆DNA测序进行胎儿唐氏综合征的无创产前筛查。
J Matern Fetal Neonatal Med. 2013 Mar;26(4):434-7. doi: 10.3109/14767058.2012.733768. Epub 2012 Oct 29.
10
Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.基于高通量测序的产前无创性胎儿三体检测在 11105 例混合危险因素妊娠中 21 三体和 18 三体的临床应用。
Prenat Diagn. 2012 Dec;32(13):1225-32. doi: 10.1002/pd.4002. Epub 2012 Nov 9.

引用本文的文献

1
NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation.母血来源游离DNA的无创产前检测:应用与实施指南
Appl Clin Genet. 2025 Apr 26;18:41-53. doi: 10.2147/TACG.S451444. eCollection 2025.
2
Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues.循环游离DNA筛查在孕期的应用拓展:当前及新出现的伦理、法律和社会问题
Curr Genet Med Rep. 2017 Mar;5(1):44-53. doi: 10.1007/s40142-017-0113-x. Epub 2017 Feb 11.
3
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling.
从母体循环中分离单个循环滋养细胞,用于无创性胎儿拷贝数变异分析。
Prenat Diagn. 2023 Jan;43(1):14-27. doi: 10.1002/pd.6275. Epub 2022 Dec 8.
4
Potential of Next-Generation Sequencing in Noninvasive Fetal Molecular Blood Group Genotyping.下一代测序技术在无创胎儿分子血型基因分型中的应用潜力
Transfus Med Hemother. 2020 Feb;47(1):14-22. doi: 10.1159/000505161. Epub 2020 Jan 20.
5
Fetal fraction and noninvasive prenatal testing: What clinicians need to know.胎儿比例与无创性产前检测:临床医生须知。
Prenat Diagn. 2020 Jan;40(2):155-163. doi: 10.1002/pd.5620. Epub 2019 Dec 10.
6
Non-invasive prenatal testing of fetal chromosomal aneuploidies: validation and clinical performance of the veracity test.胎儿染色体非整倍体的无创产前检测:准确性检测的验证及临床性能
Mol Cytogenet. 2019 Jul 15;12:34. doi: 10.1186/s13039-019-0446-0. eCollection 2019.
7
Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing.应用低深度全基因组测序进行胎儿亚染色体拷贝数变异和染色体非整倍体的无创性产前检测。
Mol Genet Genomic Med. 2019 Jun;7(6):e674. doi: 10.1002/mgg3.674. Epub 2019 Apr 19.
8
Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters.孕中期和孕晚期非侵入性产前检测、核型分析及染色体微阵列诊断胎儿染色体异常的效率比较
Front Genet. 2019 Mar 11;10:69. doi: 10.3389/fgene.2019.00069. eCollection 2019.
9
Accuracy and reproducibility of fetal-fraction measurement using relative quantitation at polymorphic loci with microarray.利用微阵列在多态性位点进行相对定量检测胎儿分数的准确性和可重复性。
Ultrasound Obstet Gynecol. 2018 Jun;51(6):813-817. doi: 10.1002/uog.19036. Epub 2018 May 3.
10
Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test.使用基于靶向微阵列的游离DNA检测进行22q11.2缺失的产前筛查。
Fetal Diagn Ther. 2018;44(4):299-304. doi: 10.1159/000484317. Epub 2017 Nov 8.